Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts

with No hi ha comentaris
  • Òdena, A., Monserrat, L., Brasó-Maristany, F., García-Galea, E., Casals, E., Molina, C.,…Serra, V. (2025). Determinants of long-term response to patritumab deruxtecan in breast cancer patient-derived xenografts. NPJ Precision Oncology, 9(1), Article 393. https://doi.org/10.1038/s41698-025-01172-5

Deixa un comentari

L'adreça electrònica no es publicarà. Els camps necessaris estan marcats amb *